OPINION You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics
INTRODUCTION
Hippocrates, the 'Father of Medicine' said, 'Let food be thy medicine and medicine be thy food'. Due to recent changes in worldwide nutritional habits, determining the interplay between diet and cell signalling is emerging as a critical area for further research. The challenge is not a new one. Previous work by Conrad Waddington, James Neel and David Barker has led to the concept that a 'thrifty phenotype' emerged during human evolution to allow the foetus to respond to environmental (primarily nutritional) cues during ontogeny (reviewed in [1] ). Currently, the average American eats around 77 pounds of added sugar every year (e.g. 22 tsp/day); thus, understanding what happens when sugars are metabolized will be of utmost importance for public health. Over the past 30 years, the understanding of O-linked N-acetylglucosamine (O-GlcNAc) cycling has had a significant impact on scientific research by defining links between sugar metabolism and altered protein function [2] . The process of O-GlcNAcylation is defined as the dynamic modification of serine or threonine amino acids by a single residue of N-acetyl glucosamine (GlcNAc) (Fig. 1) . The GlcNAc substrate is directly provided by metabolism of extracellular glucose through the hexosamine biosynthesis pathway (HBP) [1] [2] [3] . This pathway is dependent upon metabolites derived from amino acid metabolism (glutamine), lipid metabolism (Acetyl-CoA), nucleotide metabolism (UDP) and glucose metabolism (glucose-6-phosphate) (Fig. 1) . Consequently, O-GlcNAcylation is considered to be a nutrient-sensing 'rheostat' acting post-translationally upon proteins; an increase in dietary sugar percentage impacts O-GlcNAcylated protein pool [4] . Two complementary enzymes regulate this modification: O-GlcNAc transferase differs substantially from the classical static N-glycosylation and O-glycosylation and represents a new mode of regulation for a signalling pathway [5] . O-GlcNAcylation impacts many of the key signalling pathways (insulin, insulin-like growth factor, fibroblast growth factor, mitochondrial subcomplexes) known to be involved in metabolic homeostasis.
To date, almost all functional protein groups are represented among the pool of O-GlcNAcylated proteins, from structural proteins to transcription factors, including even the enzymes of O-GlcNAc cycling (OGA and OGT) [1] . The consequences of O-GlcNAcylation are likely broad, ranging from conformational changes and altered protein-protein interactions, to changes in protein half-life, subcellular localization or protein activity. By modification of a large number of proteins, O-GlcNAcylation is able to alter transcription, translation and proteasomal degradation. These processes, in turn, are known to regulate complex processes such as the cell cycle and embryonic development [1, 6] . O-GlcNAcylation has also been implicated in diseases, including neurodegeneration, cardiovascular diseases, type II diabetes and cancers. In these cases, nutrition-related deregulation could impact protein modification and exacerbate disease development [1, 6] . Because of its high dependence on glucose and other nutrient
KEY POINTS
O-GlcNAc is a nutrient-responsive post-translational modification of proteins involved in transcription, translation, protein stability and interaction. It also interacts with numerous epigenetic regulators.
O-GlcNAc Transferase (OGT), which catalyzes O-GlcNAc addition, is an X-linked gene subject to strict regulation by X-inactivation in women.
The human O-GlcNAcase (OGA) gene is a susceptibility locus for type 2 diabetes and obesity and is subject to regulation by higher order chromatin structure.
Altered O-GlcNAc cycling has been linked to chronic human diseases, including Alzheimer's disease, obesity, diabetes, systemic lupus erythematosus, cardiovascular disease and cancer.
O-GlcNAc metabolism may be particularly important in the intrauterine environment in which OGT is a key biomarker for placental stress linked to subsequent disease susceptibility. FIGURE 1. The hexosamine signalling pathway terminating in dynamic O-GlcNAc cycling. O-GlcNAc cycling is a nutrientdependent modification capable of generating a graded signalling output to a multitude of simultaneous targets. Directly supplied by the breakdown of food, 2-3% of glucose entering cells is driven to the hexosamine biosynthetic pathway to generate UDP-GlcNAc using other nutrient-derived precursors. The breakdown of foods to produce metabolites is represented by the stylized bubbles. O-GlcNAc Transferase (OGT) uses the varying levels of UDP-GlcNAc to O-GlcNAcylate serine or threonine residue of diverse intracellular proteins (nuclear, cytoplasmic or mitochondrial). The O-GlcNAcase (OGA) hydrolyzes the GlcNAc moiety and creates a dynamic posttranslational protein modification. This, in turn, impacts canonic phosphorylation-dependent signalling cascades, alters protein stability and may cause direct enzyme activation. Thus, levels of food-derived metabolites are integrated, amplified and transduced by the hexosamine signalling pathway. levels, O-GlcNAcylation is poised to regulate biological pathways in a nutrient-dependent manner. Herein, we highlight diet-responsive processes in which O-GlcNAcylation is known to be involved (Fig. 2 ). We will also emphasize the importance of this pathway in the intrauterine environment in which it may exert transgenerational effects relevant to human health and disease susceptibility.
THE INTERPLAY BETWEEN O-LINKED N-ACETYLGLUCOSAMINE AND EPIGENETICS
Epigenetics represents a way to alter the programme of development in response to dietary influences. In fact, exposing mice to a high sugar bolus triggers epigenetic changes, which could last as far as 6 days after the initial exposure, and ultimately affect their cardiovascular damage risk [7] . Interestingly, epigenetic changes can also explain how paternal diet may affect metabolic features of his offspring [8] . Due to its reactivity to glucose flux, O-GlcNAcylation is one important potential mediator of dietinduced epigenetic modification.
Since the discovery of O-GlcNAc, chromatin has been described as a major O-GlcNAc target, suggesting a key role for O-GlcNAcylation in the transcriptional regulation of genes (reviewed in [9 & ]). O-GlcNAc was found to occupy the promoters of a substantial percentage of expressing genes in Caenorhabditis elegans [10] . In addition, the O-GlcNAc modification was found directly on histones H2A, H2B, H4 and H3 [11] [12] [13] . Furthermore, OGA possesses a predicted HAT domain is similar to the histone acetyltransferase GCN5, believed to facilitate the association of OGA with histone complexes [14] . Interestingly, OGT is also found associated with epigenetic modulators, including the ten-eleven translocation (TET) proteins [15] , the mSin3A-HDACs (reviewed in [16] ) and finally the Polycomb group (PcG) proteins [17] . These recent findings are summarized below.
The transcriptional corepressor mSin3A physically interacts with OGT and is O-GlcNAcylated. OGT-mSin3A interaction is also believed to trigger the repression of specific subsets of regulatory genes, for example the retinoblastoma tumour suppressor 16] ). Under high glucose condition, OGT-mSin3a-HDAC complex is notably targeted and affects proper vascular function [18, 19] . OGT binds to the TET family proteins involved in DNA demethylation on CpG islands. OGT not only modifies TET 1, 2 and 3 proteins [15] but also interacts with them to be directed to chromatin to modify histones [20 & ]. In addition, a competition between phosphorylation and O-GlcNAcylation on TET proteins has recently been demonstrated and may regulate their functions [21] .
O-GlcNAc
In Drosophila, the PcG gene super sex combs (sxc) encodes the O-GlcNAc transferase [22] . In the same organism, major O-GlcNAc staining is found on the PcG-binding sites on polytene chromosomes [23] and a major Polycomb protein (Ph) is O-GlcNAcylated for proper functioning [24] . Although Drosophila and mammalian are obviously different, a link between PcG protein and OGT was also demonstrated in mammals in which PRC2 is needed to maintain normal OGT level in stem cells [17] .
The interplay between PcG gene silencing and O-GlcNAcylation becomes more intriguing knowing that the Oga gene is localized in the natural killer (NK) cluster, containing three homeobox gene clusters regulated by PcG repression [1,9 & ,25]. Taken together, these observations link O-GlcNAcylation to epigenetic phenomena previously shown to play key roles in differentiation and development. O-GlcNAc is also intimately involved in one of the most detailed PcG-mediated gene silencing mechanisms: the dosage compensation or X-inactivation in mammals that we detail in the next section.
DOSAGE OF OGT IS REGULATED BY IMPRINTED X-INACTIVATION
Dosage compensation mechanisms are necessary in order to balance transcription from the X-chromosome between males and females. Whereas females have two X chromosomes, males have an X and Y chromosome. In mammals, this process for dosage compensation is called X-inactivation and is defined by silencing of one of the two female X-chromosomes [26] . During early embryogenesis, X-chromosome inactivation occurs differently for extra-embryonic vs. embryonic tissues. In the extra-embryonic tissues, the paternally inherited X-chromosome (Xp) is silenced (imprinted X-inactivation, iXCI) [26] . Within the inner cell mass (ICM), from which the embryo is derived, cells undergo random X-inactivation (rXCI), for example half the cells silence the Xp and the other half silence the maternally inherited X-chromosome (Xm) [26] . Interestingly, the O-GlcNAc transferase gene is localized on the X-chromosome close to the X-inactivation centre (XIC) (reviewed in [26] ). Because Ogt is an X-linked nutrient sensor whose dosage is important for human health and disease, silencing of extra-Ogt alleles seems critical for normal female development. Indeed, heterozygous Ogt knockout female is embryonic lethal when the mutant allele is maternally inherited, whereas paternal inheritance is viable (reviewed in [26] ). In fact, in the female placenta, Ogt is only expressed by the maternal allele [27] . Consequently, because the Xp is silenced, at least a functional maternal Ogt allele seems to be required in extra-embryonic tissues for proper preimplantation development. Surprisingly though, other studies have shown that Ogt does not systematically undergo normal iXCI in extra-embryonic tissues and have therefore defined Ogt as an iXCI-escaping gene in mouse trophoblastic stem cells [28] [29] [30] [31] . Thus, female placentas sometimes have higher levels of OGT and O-GlcNAcylated proteins than male placentas [32 && ]. To summarize, Ogt seems to have a varied pattern of placental iXCI and, as a consequence, O-GlcNAcylation may be a good candidate to link maternal diet to development of the offspring. Indeed, maternal low-fat diet (high in carbohydrates) increases Ogt expression only in the female mouse placenta [33] . Similarly, as O-GlcNAcylation is involved in type-2 diabetes [34] , female rodents, who had experienced malnutrition, or defects in glucose homeostasis during perinatal development, had increased incidence of metabolic syndrome that could be explained by sex-specific O-GlcNAcylation pattern (reviewed in [26] ). Moreover, maternal high sucrose exposure during pregnancy caused glucose homeostasis defects in female but not male offspring in mice, which may be explained by O-GlcNAcylation [35] . Although diet during pregnancy does affect on offspring of both sexes, female and male mouse preimplantation embryos still have around 600 differentially expressed transcripts that could potentially explain the sex-specific sensitivity to maternal diet [36] .
DOSAGE OF OGT IS REGULATED BY RANDOM X-INACTIVATION
Compared with iXCI, from which Ogt may escape, random X-chromosome inactivation (rXCI) occurring in the embryo itself serves to silence extra-Ogt alleles. Due to its location near XIC, Ogt seems to be under tight transcriptional control in mouse embryo. Nevertheless, prior to widespread X-inactivation, most X-linked genes are biallelically expressed in mouse embryonic stem cells. However, allelic analysis in these cells indicated that Ogt expression is already monoallelic (reviewed in [26] ). This last observation suggests that, due to its close proximity to Xist locus in the XIC, Ogt can be repressed prior to rXCI in mice. But because many more X-genes escape X-inactivation in humans (15%) than in mice (3%) (reviewed in [26] ), an investigation of Ogt gene dosage in humans was necessary. Our laboratory demonstrated that only one copy of Ogt gene is also activated in female human fibroblast [37 & ]. This study also demonstrated that Ogt might be reactivated by removal of XCI repression marks on DNA. As an example, systemic lupus erythematosus (SLE) presents a reactivation of the silenced X-chromosome due to a large demethylation process and diet is thought to be a part of disease progression. Interestingly, a reactivation of Ogt is observed in SLE and is believed to worsen or even trigger this disease [38 & ]. In other words, monoallelic inactivation of Ogt likely controls OGT protein content in cells, preventing major imbalance in O-GlcNAc cycling.
INTRAUTERINE EFFECTS OF O-GLCNACYLATION
Hyperglycemia, due to diabetes or permanent high sugar consumption, makes a pregnancy high risk and can cause many negative effects on the foetus. Blood sugar is the baby's food source and it passes from the mother through the placenta. Ubiquitously present in the developing placenta and embryo, O-GlcNAcylation has been proposed to be one of the explanations of how maternal diet may effect development of the offspring [25] . Indeed, hyperglycemia-mediated O-GlcNAcylation has an impact as early as blastocyst stage of embryogenesis [39] . Similarly, creating a permanent diet-induced hyper-O-GlcNAcylation by Oga knockout triggers serious developmental defects [40 && ]. In these studies, Oga null pups exhibit a high incidence of neonatal lethality owing to decreased glycogen stores, a smaller size and a higher fat percentage.
O-GlcNAcylation is essential for proper vertebrate development. In different models (Zebrafish and Xenopus), O-GlcNAcylation has also been found critical for early development processes. More importantly, Ogt knockout causes lethality, with mouse embryos dying around 4.5 days postcoitus (blastocyst) [39] (reviewed in [26] ).
O-LINKED N-ACETYLGLUCOSAMINE IMPACTS STEM CELL BIOLOGY AND NEUROGENESIS
O-GlcNAcylation also plays a key role in stem cell biology. Numerous stem cell factors have been shown O-GlcNAcylated such as Oct4 [41] or Sox2 [42] . Whereas the role of Sox2 O-GlcNAcylation is still unclear, Oct4 interacts with OGT and is modified in order to regulate pluripotency gene networks [43] . Furthermore, elevating O-GlcNAcylation triggers alterations in stem cell differentiation, particularly described in neuronal lineages [44, 45, 46 & ]. Glucose levels were recently correlated to brain developmental delay in type 1 diabetic patients, although the mechanism of this delay was unclear from this analysis [47] . Interestingly, O-GlcNAcylation is found especially abundant in brain tissues. Furthermore, disruption of placental Ogt affects the hypothalamus-pituitary-adrenal (HPA) axis, critical for proper foetal growth and metabolism, thus linking placental Ogt with neurodevelopmental programming [48 && ]. Prenatal stress induced by loss of OGT in the placenta also induces hypothalamic mitochondrial dysfunction. In related experiments, decreasing cellular Oga also deregulates numerous genes linked to cell proliferation and metabolism, with a particular interest for Nr3c1, a gene involved in intrauterine programming of the HPA axis [40 && ]. As a consequence, the Oga null mice show a general perturbation of insulinglucose homeostasis. A key homeobox protein involved in pituitary development, Otx2, is also O-GlcNAcylated, but the role of the modification remains unknown [49] . Furthermore, secretion of orexin A and B by the hypothalamic orexin neuron, notably involved in sleep/wake and feeding behaviors, is regulated by a O-GlcNAc cycling at the pre-Orexin Hrct locus [50] . Production of Orexin stimulates orexigenic neurons such as the AgRP neurons, which are localized in the hypothalamus and stimulate metabolism. Interestingly, in AgRP neurons, removal of Ogt promotes the browning of white adipose tissue and protects mice against diet-induced obesity and insulin resistance [51] . Taken together, these findings highlight the emerging role of O-GlcNAcylation as a key player in brain-induced metabolic deregulation. O-GlcNAcylation is therefore a key regulator important for stem cell biology, neurogenesis and epigenetics and therefore is uniquely poised to integrate nutritional information during early development in the intrauterine environment.
CONCLUSION
Proper dietary balance has long been known to be critical for the maintenance of human health. Malnutrition, such as rapid increase in glucose or fat consumption, disturbs this equilibrium, with many consequences leading to the progression of human diseases linked to nutrient excess. As a nutrient sensor, O-GlcNAcylation is one of the key homeostatic mechanisms responding to dietary imbalance [52] . Such imbalance can occur due to the supplementation of our modern diet with high fructose corn syrup or by an overabundance of protein-rich animal protein and fat. Imbalance can also be introduced by dietary supplementation such as the widespread use of glucosamine supplements that directly feed into the hexosamine biosynthetic pathway driving the O-GlcNAc modification. As demonstrated in this review, O-GlcNAcylation may also be altered by epigenetic phenomena including random and incomplete X-inactivation in females [53] . OGlcNAc cycling may now be considered to be a major mediator of diet-responsive signalling and must be considered when studying nutrition-responsive diseases. Diseases linked to overnutrition including obesity, type-2 diabetes, Alzheimer's disease and cancer have all been linked to aberrant O-GlcNAcylation. As we have argued here, the intrauterine environment in which embryonic development proceeds is a locus wherein O-GlcNAc may exert its most direct effect on future disease susceptibility for the developing child. Future research is aimed at understanding how the homeostatic O-GlcNAc cycling pathway has evolved to buffer the developing foetus from metabolic perturbations at this most critical stage in human development.
